Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Identifying dysfunctional cell types and circuits in animal models for psychiatric disorders with calcium imaging
    Published on 2024-08-09
    2 years ago
  • Identification of a stress-responsive subregion of the basolateral amygdala in male rats
    Published on 2024-08-09
    2 years ago
  • Current best practices and future opportunities for reproducible findings using large-scale neuroimaging in psychiatry
    Published on 2024-08-08
    2 years ago
  • Hypocretin in the nucleus accumbens shell modulates social approach in female but not male California mice
    Published on 2024-08-08
    2 years ago
  • Applying fetal, infant, and toddler (FIT) neuroimaging to understand mental health
    Published on 2024-08-08
    2 years ago
  • Leveraging large-scale brain networks in rats to understand neurological and psychiatric disorders in humans
    Published on 2024-08-08
    2 years ago
  • Multisystem stress response biotypes: a precision psychiatry approach to identifying and treating multidimensional risk factors for anhedonia in adolescence
    Published on 2024-08-08
    2 years ago
« Previous 1 … 70 71 72 73 74 … 143 Next »
Journal of Psychopharmacology
  • The association between N-methyl-d-aspartate receptor availability and glutamate levels: A multi-modal PET-MR brain imaging study in first-episode psychosis and healthy controls
    Published on 2022-09-19
    4 years ago
  • Deepening our understanding of psychedelics by expanding psychedelic data collection in the United States National Survey on Drug Use and Health
    Published on 2022-09-16
    4 years ago
  • Prefrontal cortex and putamen grey matter alterations in cannabis and tobacco users
    Published on 2022-09-16
    4 years ago
  • Cell-based serum anticholinergic activity assay and working memory in cognitively healthy older adults before and after scopolamine: An exploratory study
    Published on 2022-09-13
    4 years ago
  • Cognition-enhancing effect of YL-IPA08, a potent ligand for the translocator protein (18 kDa) in the 5 × FAD transgenic mouse model of Alzheimer’s pathology
    Published on 2022-09-07
    4 years ago
  • Visualizing classification of drugs used in psychotic disorders: A ‘subway map’ representing mechanisms, established classes and informal categories
    Published on 2022-09-01
    4 years ago
  • Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review
    Published on 2022-08-26
    4 years ago
« Previous 1 … 70 71 72 73 74 … 145 Next »
European Neuropsychopharmacology
  • Cognitive and clinical correlates of resting-state fMRI in adults with gambling disorder
    Published on 2023-01-13
    3 years ago
  • The efficacy of lumateperone on symptoms of depression in bipolar I and bipolar II disorder: Secondary and post hoc analyses
    Published on 2023-01-13
    3 years ago
  • Clinical and developmental characteristics of cognitive subgroups in a transdiagnostic sample of schizophrenia spcectrum disorders and bipolar disorder
    Published on 2023-01-13
    3 years ago
  • Second-generation antipsychotics and seizures – a systematic review and meta-analysis of serious adverse events in randomized controlled trials
    Published on 2023-01-13
    3 years ago
  • The substantia nigra in the pathology of schizophrenia: A review on post-mortem and molecular imaging findings
    Published on 2023-01-13
    3 years ago
  • Contents
    Published on 2023-01-07
    3 years ago
  • ECNP Calendar of Meetings
    Published on 2023-01-07
    3 years ago
« Previous 1 … 70 71 72 73 74 … 166 Next »

   Pharma Pub